EG
About
Eric Goupil, CEO of Unither Pharmaceuticals, discusses the company’s development strategy moving forward after the completion of a leveraged buyout in 2017. Additionally, Goupil shares the CDMO’s innovation capabilities as a leading player in the Blow-fill-seal (BFS) niche.
Investment Focus
- Location
- France
Contact Information
linkedin.com/in/••••••••
Find more investors like Eric
Search Investors